Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27389173)

Published in BMC Cancer on July 07, 2016

Authors

Weidong Shen1, Naoko Sakamoto2, Limin Yang3,4

Author Affiliations

1: Department of Otolaryngology - Head and Neck Surgery, Chinese PLA General Hospital, The Institute of Otolaryngology, 28 Fuxing Road, Beijing, 100853, People's Republic of China.
2: Department of Epidemiology Research, Toho University, 4-16-20, Omori-Nishi Ota-ku, Tokyo, 143-0015, Japan.
3: Division of Allergy, Department of Medical Subspecialties, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan. yo-r@ncchd.go.jp.
4: Medical Support Center for Japan Environment and Children's Study, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan. yo-r@ncchd.go.jp.

Articles cited by this

Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72

Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol (2009) 3.74

Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol (2009) 3.38

Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology (2009) 3.20

Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol (2006) 2.05

Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol (2004) 1.90

Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database. Ann Surg Oncol (2010) 1.59

A competing-risks nomogram for sarcoma-specific death following local recurrence. Stat Med (2003) 1.57

Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol (2007) 1.44

Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. J Clin Oncol (2012) 1.38

Validation of cause-of-death certification for outpatient cancers: the contrasting cases of melanoma and mycosis fungoides. Am J Epidemiol (1998) 1.34

Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes. J Surg Oncol (2011) 1.29

Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society. J Clin Oncol (2004) 1.18

A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care. Gynecol Oncol (2010) 1.17

A nomogram for predicting individual survival of patients with gastric cancer who underwent radical surgery with extended lymph node dissection. Gastric Cancer (2013) 1.02

Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol (2013) 0.90

Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis. Ann Surg Oncol (2014) 0.90

Outcomes for lymph node-positive cutaneous melanoma over two decades. World J Surg (2011) 0.83

Competing risk analysis of mortality from invasive cutaneous melanoma in New South Wales: a population-based study, 1988-2007. Aust N Z J Public Health (2012) 0.83

Clinical and prognostic factors for melanoma of the skin using SEER registries: collaborative stage data collection system, version 1 and version 2. Cancer (2014) 0.83

Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions. Eur J Surg Oncol (2016) 0.79